Communities
Eric Peacock
HS Patients Share Benefits of GLP-1s on their HS Symptoms
myHSteam patients report GLP-1s reduce HS symptoms as well as impact weight or diabetes management
Communities | Product Overviews
Swoop
Smarter Intelligence, Deeper Connection: Redefining Brand Marketing in 2026
Swoop's 2026 innovations build a truly patient-first marketing strategy.
Swoop
Real-World Patient Insights on MS Treatment Revealed in New Research from Biogen, MyHealthTeam, and Spherix
“Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy,” offers real-world insights into the treatment experience for MS patients.
Swoop
MyHealthTeam Earns 22 Fall Digital Health Awards
Swoop’s commitment to patient advocacy earns top honors
Eric Peacock
Why AI is Fueling the Growth of Patient Communities
Google’s shift toward AI-generated answers removes blue search links often without clear attribution or context.
Communities | Patient Insights
Swoop
Patient Reported Impact of Psoriasis and Desired Treatment Outcomes
Understanding the holistic impact is crucial to enabling patients to live more fulfilling lives. For this research presented at the 2025 Fall Clinical Dermatology Conference, 98 members of MyPsoriasisTeam living with psoriasis were interviewed to better understand patient-desired outcomes and help dermatologists develop more effective approaches to treatment. The emotional toll of psoriasis manifests in […]
Communities | Patient Insights
Swoop
Beyond the Diagnosis: Exploring the Emotional, Physical, and Financial Toll of Lung Cancer
This research underscores the urgent need for a more patient-first approach to lung cancer care.
Communities | Patient Insights
Swoop
Patients share Experience With Ruxolitinib Cream in Vitiligo
Understanding real-world experiences with a recently approved FDA vitiligo treatment helps dermatologists set realistic expectations with their patients, which can foster increased adherence
Communities | Patient Insights
Swoop
Patient Reported Impact of Atopic Dermatitis and Desired Treatment Outcomes
AD has a moderate to severe impact on quality of life People living with atopic dermatitis (AD) often struggle with its physical symptoms and mental health toll. This research presented at the 2025 Fall Clinical Dermatology Conference aims to better understand the desired outcomes, concerns, and treatment satisfaction levels amongst patients in the MyEczemaTeam who […]
Swoop
Patients See the Value of Treatment Advertising
A Swoop survey of 902 MyHealthTeam community members with chronic conditions reveals treatment advertising influences patients and drives action.